SUMMARY Serum and intestinal secretory IgA (sIgA) were investigated in control subjects and patients with alcoholic cirrhosis of the liver. Intestinal secretions were sampled by intraluminal perfusion with a balloon catheter. Monomeric IgA and sIgA were assayed by reversed radial immunodiffusion and nephelometry after separation by Ultrogel column filtration. High levels of serum sIgA were found only in patients with severe cirrhosis accompanied by jaundice. The intestinal rate of secretion of sIgA measured in these patients was significantly lower than that observed in either the controls or the patients with compensated cirrhosis. Such an intestinal sIgA deficiency, which could be explained either by a fall in small intestinal immunocyte synthesis or by a defect in the transenterocyte transport system, could be partially responsible for the high incidence of intestinal infection observed in severe cirrhosis.
The presence of secretory IgA (sIgA) in human serum is well documented. 1-Liver diseases, notably alcoholic cirrhosis of the liver, are associated with abnormally high amounts of sIgA in serum.46 In these cases, the observed structure of serum sIgA is identical with that of the sIgA found in external secretions.7 Apart from hypogammaglobulinaemia, the secretory component has never been detected free in serum; it has rather always been detected as covalently linked to dimeric IgA.1 3 7 Reports of small intestine involvement in cirrhosis8 decided us to undertake a parallel study of sIgA in serum and intestinal secretions in normal and cirrhotic subjects.
Methods

PATIENTS
These investigations were performed on three healthy subjects and six patients with alcoholic cirrhosis, three of whom presented serious signs of disease with jaundice (corresponding to Child's type C),9 while, in the other three, cirrhosis was compensated (Child's type A or B). The diagnosis of cirrhosis in each case was made on the basis of clinical and histological criteria and laboratory results. None of the subjects studied had received Received for publication 26 the sampling point. The segment explored extended from the balloon to point 40 cm distal to it. A SCOP PS 20 pump was used for perfusion at a constant rate of about 10 ml/mn (9.52-11.05 ml/mn). The tracer used was polyethyleneglycol (PEG) 4000, diluted at a concentration of 10 g/l in physiological saline solution and detected by Hyden's method. 12 The flow rate (D) of a given substance (S) is given by the formula:
in which Vi is the perfusion rate, Si and S2 the concentrations of S at the perfusion and sampling points (here, S1=0), and PEG1 and PEG2 the tracer concentrations at these points.
In order to reach equilibrium, samples were taken only after one hour and secreted jejunal fluid was collected for one hour. The samples were stored at -20°C after the enzymatic inhibitor diisopropylfluorophosphate (DFP) had been added. Freezing at -20°C and the addition of DFP were confirmed to have no effect on the 7SIgA and sIgA levels measured.
Separation and detection of IgA intestinal juice
The jejunal juice was concentrated 20 to 50 times and then dialysed against phosphate buffered saline.
Monomeric IgA (7S IgA) was separated from polymeric IgA by gel filtration: a 0.6 ml sample of concentrate was applied to a 1.6x100 cm column (Pharmacia) of ACA 34 Ultrogel (IBF) at a flow rate of 4.4 ml/h. An example of the optical density of the eluted proteins is given in Fig. 1 .
The IgA in the unconcentrated jejunal juice and its eluates was assayed without prior concentration by two techniques. The first employed nephelo- The second assay method that was used was reversed radial immunodiffusion, for which the jejunal juice was incorporated into an agarose support, with the anti-a chain immune serum (CDTS Bois Guillaume), used in dilutions of 1/1, 1/2, 1/4, and 1/8, placed in wells from which it was allowed to migrate by diffusion. The IgA level was measured in relation to that of a human serum containing a known amount of IgA. This procedure has been shown to underestimate the 11S IgA level by a factor close to 2.13
These two techniques were found to yield identical results (Fig. 2 ).
Serum albumin and jejunal liquid albumin levels These were determined by radial immunodiffusion (Institut Pasteur production: Proteiplaques).
Statistical analysis Analysis of the results was performed by the Mann-Whitney U test. All significance levels quoted are one-tailed. We found this rise in three cases of severe cirrhosis with jaundice. On the other hand, the serum sIgA level was observed to be normal in the three cases of compensated cirrhosis, none of which was associated with jaundice. The presence or absence of cholestasis in these two groups of patients may in part explain this difference. In this connection, it was shown recently that experimentally produced bile duct obstruction in rats produced a rapid and considerable increase in the serum sIgA level. ' Furthermore, F and C Andre5 have shown that the considerable increase in serum IgA seen in cirrhosis is due in large part to a rise in dimeric IgA, the concentration of which was found to be about seven times higher than normal. This implies that some of the dimeric IgA which is accumulated in the serum may arise from that secreted by the intestinal immunocytes which is neither secreted as sIgA into the intestinal liquid nor secreted into the bile. 4 The sIgA secreted into the intestine could be reabsorbed by the altered mucosa, but this possibility is unlikely, as it was shown that the uptake of dimeric IgA from the intestine into the serum is inhibited by the presence of secretory component on IgA. 29 The lowered intestinal sIgA level observed in our cases of severe cirrhosis may lead to a defective small intestinal defence system and hence be partially responsible for the increased incidence of infection-diarrhoea, septicaemia of digestive origin, or of infected ascites that is observed in such patients.
